Category: Quality Measures

Percentage of patients with a diagnosis of diabetic macular edema with a loss of less than 3 Snellen lines (which is equivalent to less than 0.3 logMAR) within the past 12 months.

Percentage of patients with acute anterior uveitis post-treatment with Grade 0 anterior chamber cells

Percentage of patients with an uncorrected visual acuity (UCVA) of 20/20 or better within 30 days

Percentage of endothelial keratoplasty patients with a rebubbling or revision or repair procedure within 90 days after surgery

Percentage of patients who underwent trabeculectomy or aqueous shunt procedure who had IOP reduced by 20% or more from their pretreatment between 3 and 4 months of treatment or a reduction in overall number of glaucoma medications.

Percentage of newly diagnosed amblyopic patients with one or more of the following: A. a corrected interocular (or if not reported, the uncorrected) visual acuity difference less than 0.23 logMAR 3-12 months after first diagnosis of amblyopia OR B. an improvement in the corrected visual acuity of the amblyopic eye of 3 or more Snellen lines (> or = 0.30 logMAR) 3-12 months after first diagnosis of amblyopia OR C. a final visual acuity in the amblyopic eye equal to 20/30 or better (less than or equal to 0.18 log Mar) 3-12 months after first diagnosis of amblyopia

Percentage of eyes of patients aged 18 years and older with a diagnosis of cataract who had cataract surgery and had the following complications with 90 days after cataract surgery: prolonged inflammation, incision complications, iris complications, retinal detachment, cystoid macular edema, corneal complications, or a return to OR.

Percentage of patients with a 20% or greater improvement in visual acuity within 120 days following vitrectomy for complications of diabetic retinopathy